Literature DB >> 26493937

Blood or sputum eosinophils to guide asthma therapy?

Manali Mukherjee1, Parameswaran Nair2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26493937     DOI： 10.1016/S2213-2600(15)00419-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  15 in total

Review 1.  Role of Biologics in Asthma.

Authors:  Mary Clare McGregor; James G Krings; Parameswaran Nair; Mario Castro
Journal:  Am J Respir Crit Care Med       Date:  2019-02-15       Impact factor: 21.405

2.  Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airway dysfunction with type 2 inflammation.

Authors:  Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2017-05-17       Impact factor: 4.962

3.  Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs.

Authors:  Lisa Ha-Yeon Kim; Karin Plaza; Sruthi R Thomas; Christina Draijer; Katherine Radford; Marc Peters-Golden; Manali Mukherjee; Parameswaran Nair
Journal:  J Immunol Methods       Date:  2017-11-14       Impact factor: 2.303

Review 4.  Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

Authors:  Gilda Varricchi; Gianenrico Senna; Stefania Loffredo; Diego Bagnasco; Matteo Ferrando; Giorgio Walter Canonica
Journal:  Front Immunol       Date:  2017-03-10       Impact factor: 7.561

5.  Asthma-COPD overlap is not a homogeneous disorder: further supporting data.

Authors:  Luis Pérez-de-Llano; Borja G Cosio
Journal:  Respir Res       Date:  2017-11-02

6.  Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.

Authors:  Annette T Hastie; Fernando J Martinez; Jeffrey L Curtis; Claire M Doerschuk; Nadia N Hansel; Stephanie Christenson; Nirupama Putcha; Victor E Ortega; Xingnan Li; R Graham Barr; Elizabeth E Carretta; David J Couper; Christopher B Cooper; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Wanda K O'Neal; Richard Paine; Stephen P Peters; Neil E Alexis; Prescott G Woodruff; MeiLan K Han; Deborah A Meyers; Eugene R Bleecker
Journal:  Lancet Respir Med       Date:  2017-11-13       Impact factor: 30.700

Review 7.  Eosinophils Target Therapy for Severe Asthma: Critical Points.

Authors:  L Brussino; E Heffler; C Bucca; S Nicola; G Rolla
Journal:  Biomed Res Int       Date:  2018-10-25       Impact factor: 3.411

Review 8.  Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

Authors:  Konstantinos Kostikas; Caterina Brindicci; Francesco Patalano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 9.  Allergic Bronchopulmonary Aspergillosis-A Luminal Hypereosinophilic Disease With Extracellular Trap Cell Death.

Authors:  Shigeharu Ueki; Akira Hebisawa; Masashi Kitani; Koichiro Asano; Josiane S Neves
Journal:  Front Immunol       Date:  2018-10-11       Impact factor: 7.561

10.  Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

Authors:  Luis Pérez de Llano; Borja G Cosío; Amanda Iglesias; Natividad de Las Cuevas; Juan Jose Soler-Cataluña; Jose Luis Izquierdo; Jose Luis López-Campos; Carmen Calero; Vicente Plaza; Marc Miravitlles; Alfons Torrego; Eva Martinez-Moragon; Joan B Soriano; Antolin Lopez Viña; Irina Bobolea
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.